Evolutionary Genomics, Inc.
FNAM · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | -89.8% | – |
| Cost of Goods Sold | $1 | $1 | $0 | $0 |
| Gross Profit | -$1 | -$1 | -$2 | -$0 |
| % Margin | – | – | -14,245.2% | -67.8% |
| R&D Expenses | $0 | $1 | $2 | $0 |
| G&A Expenses | $2 | $2 | $1 | $0 |
| SG&A Expenses | $1 | $2 | $1 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$1 | -$2 | $0 |
| Operating Expenses | $1 | $2 | $1 | $1 |
| Operating Income | -$2 | -$3 | -$3 | -$1 |
| % Margin | – | – | -23,038.4% | -631.6% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | -$2 | -$3 | -$3 | -$1 |
| Tax Expense | $0 | $0 | -$1 | $0 |
| Net Income | -$2 | -$3 | -$2 | -$1 |
| % Margin | – | – | -13,695.1% | -646.5% |
| EPS | -0.35 | -0.52 | -0.34 | -0.13 |
| % Growth | 32.7% | -52.9% | -161.5% | – |
| EPS Diluted | -0.35 | -0.52 | -0.34 | -0.13 |
| Weighted Avg Shares Out | 6 | 6 | 6 | 6 |
| Weighted Avg Shares Out Dil | 6 | 6 | 6 | 6 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $0 | $0 |
| EBITDA | -$1 | -$2 | -$2 | -$1 |
| % Margin | – | – | -19,763.4% | -598.4% |